Drug Type Inactivated vaccine, Prophylactic vaccine, Multivalent vaccine |
Synonyms TDENV PIV, TDENV-PIV, Tetravalent purified inactivated dengue vaccine |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dengue | Phase 2 | United States | 01 Aug 2015 | |
Dengue | Phase 2 | United States | 01 Aug 2015 |
Phase 1 | 100 | (TDENV-PIV alum1) | rnsjktjdxs = czjutrrxhj hclpdfybot (fjrtmvcbvd, nbijttpqdq - dowbbshugs) View more | - | 25 Jan 2019 | ||
(TDENV-PIV alum4) | rnsjktjdxs = nhqrhizrta hclpdfybot (fjrtmvcbvd, abcbudkcdg - bqwtkhqdkn) View more |